相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Case-Control Study of Drug Monitoring of β-Lactams in Obese Critically Ill Patients
Maya Hites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
Gloria Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia
Yoshiro Hayashi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients
Fleur Wolff et al.
TALANTA (2013)
Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections
Lutz Binder et al.
THERAPEUTIC DRUG MONITORING (2013)
Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Optimal Meropenem Concentrations To Treat Multidrug-Resistant Pseudomonas aeruginosa Septic Shock
Fabio Silvio Taccone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations
Bernard Georges et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients Association Between Augmented Renal Clearance and Low Trough Drug Concentrations
Andrew A. Udy et al.
CHEST (2012)
Pharmacokinetics of Ampicillin/Sulbactam in Critically Ill Patients with Acute Kidney Injury undergoing Extended Dialysis
Johan M. Lorenzen et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Survival in neutropenic patients with severe sepsis or septic shock
Matthieu Legrand et al.
CRITICAL CARE MEDICINE (2012)
Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method
Mieke Carlier et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients-A One-Year Prospective Study
Bhavik M. Patel et al.
THERAPEUTIC DRUG MONITORING (2012)
TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
Federico Pea et al.
ANNALS OF PHARMACOTHERAPY (2011)
Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal
Denis Garot et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience
E. Nagy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Appropriate Antibiotic Dosage Levels in the Treatment of Severe Sepsis and Septic Shock
Fabio Silvio Taccone et al.
Current Infectious Disease Reports (2011)
Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration
I. Bilgrami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function
F. Lamoth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
Andrew A. Udy et al.
CLINICAL PHARMACOKINETICS (2010)
Daily serum piperacillin monitoring is advisable in critically ill patients
Nicolas Blondiaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007
Catherine Dumartin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics
Marta Ulldemolins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008
Elisabeth Meyer et al.
CRITICAL CARE (2010)
Prospective monitoring of cefepime in intensive care unit adult patients
Thomas M. Chapuis et al.
CRITICAL CARE (2010)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey, 2005
Mari Kanerva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antibiotic resistance: location, location, location
D. M. Livermore et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
Chonghua Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SATE) study
Simon Finfer et al.
BRITISH MEDICAL JOURNAL (2006)
Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection
Irma A. J. M. Bakker-Woudenberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Cost-effectiveness of therapeutic drug monitoring - A systematic review
DJ Touw et al.
THERAPEUTIC DRUG MONITORING (2005)
Pharmacokinetics and pharmacodynamics of meropenern in febrile neutropenic patients with bacteremia
RE Ariano et al.
ANNALS OF PHARMACOTHERAPY (2005)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study
P Malacarne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form
ASL Mendez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2003)
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
J Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2003)
Population pharmacokinetics of ceftazidime in burn patients
E Dailly et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
S Harbarth et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Pharmacodynamics of cefepime in patients with Gram-negative infections
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
分享论文
